The Power of Numerical Indicators in Predicting Bankruptcy: A Systematic Review
Journal of Risk and Financial Management · 28.09.2024 · 17 (10) · 433
DOI: 10.3390/jrfm17100433 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Risk and Financial Management, online erschienen am 28.09.2024. Verfasst von Dimitrios Billios und 2 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper systematically reviews the behavior of numerical indicators in predicting future bankruptcy of companies through statistical analysis models. Following the PRISMA standard, ten primary studies were included in the review. The obtained results underline (1) the ability of numerical indicators, through simple statistical analysis models, to forecast the bankruptcy of businesses and companies and (2) the reliability of cash flows in predicting financial distress through statistical analysis, and (3) models are built with indicators from a specific economy; it is impossible to consider them stable and unchanging, as changes in a country’s economic conditions can potentially impact their predictive accuracy.
Zitieren
APA
Billios, D., Seretidou, D., & Stavropoulos, A. (2024). The Power of Numerical Indicators in Predicting Bankruptcy: A Systematic Review. Journal of Risk and Financial Management, 17(10), 433. https://doi.org/10.3390/jrfm17100433
Vancouver
Billios D, Seretidou D, Stavropoulos A. The Power of Numerical Indicators in Predicting Bankruptcy: A Systematic Review. Journal of Risk and Financial Management. 2024;17(10):433. doi:10.3390/jrfm17100433
BibTeX
@article{Billios2024,
author = {Billios, Dimitrios and Seretidou, Dimitra and Stavropoulos, Antonios},
title = {The Power of Numerical Indicators in Predicting Bankruptcy: A Systematic Review},
journal = {Journal of Risk and Financial Management},
year = {2024},
volume = {17},
number = {10},
pages = {433},
doi = {10.3390/jrfm17100433}
}
EUVIMED